AzTrials
AzTrials

StrokeNCT07869667

NEURO-MODULATORY EFFECT OF ELECTRO-ACUPUNCTURE ON COMPLEX REGIONAL PAIN SYNDROME IN POST STROKE PATIENTS

A study testing Electroacupuncture and Conventional physical therapy program in people with Stroke, run by Ahmed Alshimy at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Improvement in pain and range of motion (ROM) outcomes for stroke cases suffering from complex regional pain syndrome (CRPS) can be attained through Electro-acupuncture therapy, which in turn improve functional independence and reduces financial strain on both patients and their families. Read more about this study

Who is it for?
Ages 45 years and older
Conditions the study is for
Stroke
What is being tested?
Electroacupuncture and Conventional physical therapy program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
5 Jan 2026to 24 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patients were diagnosed clinically and referred from a neurologist
  • The study included cases who were 45 years old or more
  • Ischemic stroke at least six months following the stroke, were receiving treatment at the outpatient clinic, and demonstrated satisfactory cognitive function (Montreal Cognitive Assessment score of more than 26), spasticity of the limbs ranging from grade 1+ (2) on a modified Ashworth scale, and a confirmed diagnosis of CRPS by clinical assessment by a neurologist using the Budapest criteria for diagnosis of CRPS.
  • Unilateral upper-limb or shoulder pain persisting for at least four weeks and up to six months following the onset of stroke. Pain intensity rated ≥ 4/10 on the Visual Analogue Scale (VAS) at rest or with active/passive shoulder movement.

Who cannot join

  • Patients with current history of hand troubles and shoulder dysfunction before developing a stroke.
  • Patients with overactive sympathetic system from other causes e.g. congestive heart failure, impaired kidney functions.
  • Patients with significant musculoskeletal disorders which include rheumatoid arthritis or metabolic disorders comprising diabetes, Patients with cognitive impairments, Visual, auditory and speech problems and Patients with psychiatric disorders or seizures.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Al Ryada University for Science and Technology

    Sadat, Menoufia

Other trials in Egypt

About this study

Improvement in pain and range of motion (ROM) outcomes for stroke cases suffering from complex regional pain syndrome (CRPS) can be attained through Electro-acupuncture therapy, which in turn improve functional independence and reduces financial strain on both patients and their families.

Read the detailed description

Group A received three sessions weekly of selected physical therapy program and electroacupuncture therapy, while Group B received the same selected physical therapy program alone. The Visual Analogue Scale (VAS) was used to assess pain, the Kinovea-based measurement was used to evaluate shoulder flexion ROM; and the Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH)-Arabic version was used to assess functional independence.

Conditions
Stroke
Being tested
Electroacupuncture, Conventional physical therapy program
Keywords
Stroke, Complex Regional Pain Syndrome, Electro-acupuncture
Medical subject headings
Stroke, Complex Regional Pain Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ElectroacupunctureOther

    Sterile, single-use stainless-steel acupuncture needles (0.25 × 30 mm) were inserted at six acupoints on the affected side: TE14., SI9., and GB21(shoulder region); LI11 and TE5 (elbow and forearm); and TE2 (dorsum of the hand)

  • Conventional physical therapy programOther

    (1) passive and active-assisted range of motion exercises (5-10 repetitions per movement, 10-15 second holds) (2) desensitization techniques using graded textures (cotton, sponge, Velcro, toothbrush), progressing from light touch to deep pressure, combined with contrast baths (3) therapeutic exercises, beginning with isometric strengthening and progressing to isotonic exercises as tolerated, followed by functional task-based activities targeting coordination and strength; (4) a structured stress-loading program involving active movement and joint compression, including quadruped scrubbing with the affected hand (5) heat therapy using hot packs for pain relief and (6) graded motor imagery, progressing through laterality training, explicit motor imagery, and mirror visual feedback. Each session began with a 5-minute warm-up and ended with a 5-minute cool-down.

Study groups in NCT07869667
Study groupRoleWhat they receive
Group AExperimentalConsisted of 20 patients who received a selected physical therapy program and electroacupuncture. The treatment was conducted for four weeks, three sessions weekly for 12 sessions
Receives: Other: Electroacupuncture; Other: Conventional physical therapy program
Group BExperimentalConsisted of 20 cases who received the same selected physical therapy program only, for four weeks, three sessions weekly for 12 sessions.
Receives: Other: Conventional physical therapy program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analogue scale

    Subjective pain assessment

    Measured: 4 weeks

  2. Kinovea-based measurement for shoulder flexion

    Shoulder flexion range of motion (ROM) assessment was conducted using Kinovea-2020 software following a standardized protocol

    Measured: 4 weeks

  3. Arabic version of DASH questionnaire

    Designed to quantify functional limitations and symptoms affecting the arm, shoulder, and hand region

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2026
  2. Study start5 Jan 2026
  3. Primary completion12 Jul 2026
  4. Study completion24 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07869667
Sponsor's protocol ID
P.T.REC/012/006119
Status last verified
Oct 2025
First submitted
6 Oct 2026
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Electroacupuncture and Conventional physical therapy program in people with Stroke, run by Ahmed Alshimy at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analogue scale (time frame: 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in